Biomarkers and the Clinical labortatory

Cards (21)

  • What is a biomarker?
    A characteristic that is objectively measured and evaluated as an indicator of biological processes.
  • What are diagnostic biomarkers used for?
    To detect disease early and classify disease type.
  • What is the purpose of predictive biomarkers?
    To identify likely responders and those likely to have an adverse event.
  • How do metabolism biomarkers assist in drug therapy?
    They aid in defining drug doses.
  • What do outcome biomarkers indicate?
    Response to therapy, indication of progression, and evidence of recurrence.
  • What is the role of the diagnostics industry in biomarker development?
    • Turns concepts into practical tools
    • Collaborates with clinical biochemistry laboratories
    • Evaluates tools in real-life practice
  • What is the time frame for moving biomarkers from research to routine use?
    Often years.
  • What are the responsibilities of research laboratories in biomarker development?
    To undertake validation of assay performance and provide clinical data.
  • What is meant by assay performance in biomarker research?
    It includes reproducibility, detection limit, accuracy, and robustness.
  • What is the detection limit in biomarker assays?
    The lowest reportable concentration.
  • Why is it important to investigate pre-analytical requirements early in biomarker research?
    To ensure specimen quality and reliability of results.
  • What are some examples of pre-analytical requirements for biomarker testing?
    Specimen type, timing, and storage requirements.
  • What defines a specialist assay in biomarker testing?
    Small workload, rare clinical conditions, or complex clinical interpretation.
  • What are the early requirements for introducing a new routine test?
    Evidence that the test improves patient management and a business case for funding.
  • What are the pre-analytical requirements for introducing a new routine test?
    No special handling required, good stability, and awareness of medication effects.
  • What is the workload of the Clinical Biochemistry lab at the Royal Infirmary?
    ~800,000 samples/year and ~5 million tests in total.
  • How does sample reception work in the Clinical Biochemistry lab?
    Specimens are barcoded during the booking-in process.
  • What are the analytical considerations for introducing a new test?
    Automation, internal quality control, and external quality assessment must be in place.
  • What is the process of sample analysis in a modern hospital lab?
    Samples are sorted, analyzed, and results are uploaded for checking.
  • What are the conclusions regarding the introduction of new biomarkers?
    • Evidence supports clinical utility
    • Funding can be assured
    • Automation is feasible for high workloads
    • Quality is verified through IQC and EQA
  • What mechanisms should be in place for new biomarker tests?
    To ensure tests are done only for those likely to benefit.